Literature DB >> 32295804

Acute Hyperglycemia Increases Brain Pregenual Anterior Cingulate Cortex Glutamate Concentrations in Type 1 Diabetes.

Nicolas R Bolo1,2, Alan M Jacobson3, Gail Musen2,4, Matcheri S Keshavan5,2, Donald C Simonson6.   

Abstract

The brain mechanisms underlying the association of hyperglycemia with depressive symptoms are unknown. We hypothesized that disrupted glutamate metabolism in pregenual anterior cingulate cortex (ACC) in type 1 diabetes (T1D) without depression affects emotional processing. Using proton MRS, we measured glutamate concentrations in ACC and occipital lobe cortex (OCC) in 13 subjects with T1D without major depression (HbA1c 7.1 ± 0.7% [54 ± 7 mmol/mol]) and 11 healthy control subjects without diabetes (HbA1c 5.5 ± 0.2% [37 ± 3 mmol/mol]) during fasting euglycemia followed by a 60-min +5.5 mmol/L hyperglycemic clamp (HG). Intrinsic neuronal activity was assessed using resting-state blood oxygen level-dependent functional MRI to measure the fractional amplitude of low-frequency fluctuations in slow-4 band (fALFF4). Emotional processing and depressive symptoms were assessed using emotional tasks (emotional Stroop task, self-referent encoding task [SRET]) and clinical ratings (Hamilton Depression Rating Scale [HAM-D], Symptom Checklist-90 Revised [SCL-90-R]), respectively. During HG, ACC glutamate increased (1.2 mmol/kg, 10% P = 0.014) while ACC fALFF4 was unchanged (-0.007, -2%, P = 0.449) in the T1D group; in contrast, glutamate was unchanged (-0.2 mmol/kg, -2%, P = 0.578) while fALFF4 decreased (-0.05, -13%, P = 0.002) in the control group. OCC glutamate and fALFF4 were unchanged in both groups. T1D had longer SRET negative word response times (P = 0.017) and higher depression rating scores (HAM-D P = 0.020, SCL-90-R depression P = 0.008). Higher glutamate change tended to associate with longer emotional Stroop response times in T1D only. Brain glutamate must be tightly controlled during hyperglycemia because of the risk for neurotoxicity with excessive levels. Results suggest that ACC glutamate control mechanisms are disrupted in T1D, which affects glutamatergic neurotransmission related to emotional or cognitive processing. Increased prefrontal glutamate during acute hyperglycemic episodes could explain our previous findings of associations among chronic hyperglycemia, cortical thinning, and depressive symptoms in T1D.
© 2020 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32295804      PMCID: PMC7306132          DOI: 10.2337/db19-0936

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  53 in total

Review 1.  Glutamate receptor trafficking in synaptic plasticity.

Authors:  Anis Contractor; Stephen F Heinemann
Journal:  Sci STKE       Date:  2002-10-29

Review 2.  The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review.

Authors:  K D Barnard; T C Skinner; R Peveler
Journal:  Diabet Med       Date:  2006-04       Impact factor: 4.359

3.  An improved approach to detection of amplitude of low-frequency fluctuation (ALFF) for resting-state fMRI: fractional ALFF.

Authors:  Qi-Hong Zou; Chao-Zhe Zhu; Yihong Yang; Xi-Nian Zuo; Xiang-Yu Long; Qing-Jiu Cao; Yu-Feng Wang; Yu-Feng Zang
Journal:  J Neurosci Methods       Date:  2008-04-22       Impact factor: 2.390

Review 4.  Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings.

Authors:  J J Luykx; K G Laban; M P van den Heuvel; M P M Boks; R C W Mandl; R S Kahn; S C Bakker
Journal:  Neurosci Biobehav Rev       Date:  2011-06-06       Impact factor: 8.989

Review 5.  The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research.

Authors:  Meysam Amidfar; Marie Woelfer; Gislaine Z Réus; João Quevedo; Martin Walter; Yong-Ku Kim
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-06-14       Impact factor: 5.067

6.  Increased brain monocarboxylic acid transport and utilization in type 1 diabetes.

Authors:  Graeme F Mason; Kitt F Petersen; Vincent Lebon; Douglas L Rothman; Gerald I Shulman
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

7.  Altered neuronal spontaneous activity correlates with glutamate concentration in medial prefrontal cortex of major depressed females: An fMRI-MRS study.

Authors:  Xiaoliu Zhang; Yingying Tang; Mirjana Maletic-Savatic; Jianhua Sheng; Xuanhong Zhang; Yajing Zhu; Tianhong Zhang; Junjie Wang; Shanbao Tong; Jijun Wang; Yao Li
Journal:  J Affect Disord       Date:  2016-05-12       Impact factor: 4.839

8.  Intrinsic cerebral activity at resting state in adults with major depressive disorder: A meta-analysis.

Authors:  Ming Zhou; Xinyu Hu; Lu Lu; Lianqing Zhang; Lizhou Chen; Qiyong Gong; Xiaoqi Huang
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-02-04       Impact factor: 5.067

Review 9.  Epidemiology of depression and diabetes: a systematic review.

Authors:  Tapash Roy; Cathy E Lloyd
Journal:  J Affect Disord       Date:  2012-10       Impact factor: 4.839

10.  The oscillating brain: complex and reliable.

Authors:  Xi-Nian Zuo; Adriana Di Martino; Clare Kelly; Zarrar E Shehzad; Dylan G Gee; Donald F Klein; F Xavier Castellanos; Bharat B Biswal; Michael P Milham
Journal:  Neuroimage       Date:  2009-09-24       Impact factor: 6.556

View more
  3 in total

1.  Modulatory effects of photobiomodulation in the anterior cingulate cortex of diabetic rats.

Authors:  Igor Rafael Correia Rocha; Marucia Chacur
Journal:  Photochem Photobiol Sci       Date:  2021-05-30       Impact factor: 3.982

2.  Hyperglycemia and hyperinsulinemia effects on anterior cingulate cortex myoinositol-relation to brain network functional connectivity in healthy adults.

Authors:  Nicolas R Bolo; Alan M Jacobson; Gail Musen; Donald C Simonson
Journal:  J Neurophysiol       Date:  2022-04-13       Impact factor: 2.974

3.  Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT and EDIC Study.

Authors:  Alan M Jacobson; Christopher M Ryan; Barbara H Braffett; Rose A Gubitosi-Klug; Gayle M Lorenzi; José A Luchsinger; Victoria R Trapani; Ionut Bebu; Naomi Chaytor; Susan M Hitt; Kaleigh Farrell; John M Lachin
Journal:  Lancet Diabetes Endocrinol       Date:  2021-05-27       Impact factor: 44.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.